You are seeing these quotes based on previous browsing related to sectors such as
Latest | Forecast | |
---|---|---|
Div Yield | 0.0% | 0.0% |
Div Cover | n/a | n/a |
Op Mrgn | -1,326.0% | -977.3% |
ROCE | 0.0% |
Latest | Forecast | |
---|---|---|
P/E | -15.4 | 0.0 |
PEG | 0.0 | -999,999.0 |
Price / Revenue | 217.8 | 81.0 |
Price / Book value | 6.2 |
Latest | Forecast | |
---|---|---|
Revenue | 27.7% | -38.5% |
PBT | 0.0% | n/a |
EPS | 0.0% | 54.7% |
DPS | n/a | 0.0% |
Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
---|---|---|---|---|---|---|---|---|
2016-04-30 | 0.36 | -5.43 | -8.69p | -7.8 | 0.0 | n/a | n/a | 0.0% |
2017-04-30 | 0.50 | -7.41 | -8.95p | -5.8 | 0.0 | n/a | n/a | 0.0% |
2018-04-30 | 0.63 | -8.93 | -7.91p | -6.0 | 0.0 | n/a | n/a | 0.0% |
2019-04-30 | 0.68 | -10.87 | -6.56p | -11.6 | 0.0 | n/a | n/a | 0.0% |
2019-12-31 | 0.58 | -7.73 | -5.69p | -11.0 | 0.0 | n/a | n/a | 0.0% |
Angle looks to raise up £20.0m via conditional placing Sharecast News | 27 Oct |
---|---|
FDA accepts Angle's review submission for Parsortix PC1 Sharecast News | 20 Oct |
Angle's Parsortix displays potential use for detection of immunotherapy efficacy Sharecast News | 14 Aug |
Update on submission for FDA clearance | 04-Mar-21 07:00 |
---|---|
Parsortix-harvested CTCs uncover novel biomarker | 18-Feb-21 07:00 |
Parsortix: Dynamic assessment of patient response | 08-Feb-21 07:01 |
Parsortix demonstrates high capture rate of CTCs | 29-Jan-21 07:00 |
Holding(s) in Company | 26-Jan-21 13:02 |